Karyopharm Therapeutics Inc. (KPTIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0089 (-26.25%)
At close: Nov 20, 2026
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 228 employees as of December 31, 2025. The number of employees decreased by 51 or 18.28% compared to the previous year. That makes Karyopharm Therapeutics the 25,848th largest employer in the world and 3,276th in the United States.
Employees
228
Change (1Y)
-51
Growth (1Y)
-18.28%
Revenue / Employee
$643,075
Profits / Employee
-$985,702
Market Cap
567.04K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 228 | -51 | -18.28% |
| Dec 31, 2024 | 279 | -46 | -14.15% |
| Dec 31, 2023 | 325 | -60 | -15.58% |
| Dec 31, 2022 | 385 | -57 | -12.90% |
| Dec 31, 2021 | 442 | 10 | 2.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Karyopharm Therapeutics News
- 5 days ago - Karyopharm Announces FDA Acceptance of Supplemental New Drug Application for XPOVIO® (selinexor) Plus Ruxolitinib for the Treatment of Patients with Myelofibrosis - PRNewsWire
- 17 days ago - Karyopharm to Present Selinexor Data in Patients with Myelofibrosis and Multiple Myeloma at the 68th American Society of Hematology Annual Meeting and Exposition (ASH) - PRNewsWire
- 20 days ago - Karyopharm Therapeutics Inc. Announces Planned Merger with Ayrmid Ltd. to Strengthen Company for the Future - PRNewsWire
- 7 weeks ago - Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis - PRNewsWire
- 3 months ago - Karyopharm Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 3 months ago - Karyopharm Therapeutics Earnings release: Q2 2026 - Filings